APO RESEARCH · REPORT
Cyclodextrin in Pharma
Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits joined by α-1,4 glycosidic bonds. Cyclodextrins are produced from starch by enzymatic conversion. They are used in food, pharmaceutical, drug delivery, and chemical industries, as well as agriculture and environmental engineering.
Product & engineering
Understand the product.
Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits joined by α-1,4 glycosidic bonds. Cyclodextrins are produced from starch by enzymatic conversion. They are used in food, pharmaceutical, drug delivery, and chemical industries, as well as agriculture and environmental engineering.
Selected research
Market Structure
Global Cyclodextrin in Pharma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits joined by α-1,4 glycosidic bonds. Cyclodextrins are produced from starch by enzymatic conversion. They are used in food, pharmaceutical, drug delivery, and chemical industries, as well as agriculture and environmental engineering.
Global key manufacturers of cyclodextrin in pharma include Wacker, Ensuiko Sugar Refining, Ashland, etc. Global top 3 manufacturers hold a share above 60%. Europe and North America are the major producing regions in the world, followed by China and Japan. In terms of application, the product is most widely used in tablets and capsules, followed by injectables.
The report provides an overview of the global Cyclodextrin in Pharma market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Cyclodextrin in Pharma and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cyclodextrin in Pharma sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cyclodextrin in Pharma market size, projected growth trends, production technologies, key applications, and end-use industries.
Cyclodextrin in Pharma Segment by Company
Wacker
Ensuiko Sugar Refining
Nihon Shokuhin Kako
Roquette
Ashland
Shandong Xinda
Yunan Yongguang
Qufu Tianli
Zibo Qianhui
Jiangsu Fengyuan
Mengzhou Huaxing
Mengzhou Hongji
Cyclodextrin in Pharma Segment by Type
Alpha-Cyclodextrin in Pharma
Beta-Cyclodextrin in Pharma
Gamma-Cyclodextrin in Pharma
CD Derivatives
Cyclodextrin in Pharma Segment by Application
Tablets and Capsules
Injectables
Cyclodextrin in Pharma Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclodextrin in Pharma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyclodextrin in Pharma and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclodextrin in Pharma.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cyclodextrin in Pharma market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cyclodextrin in Pharma industry.
Chapter 3: Detailed analysis of Cyclodextrin in Pharma market competition landscape. Including Cyclodextrin in Pharma manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Cyclodextrin in Pharma by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Cyclodextrin in Pharma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Alpha-Cyclodextrin in Pharma
- Beta-Cyclodextrin in Pharma
- Gamma-Cyclodextrin in Pharma
- CD Derivatives
Applications
- Tablets and Capsules
- Injectables
Companies covered
- Wacker
- Ensuiko Sugar Refining
- Nihon Shokuhin Kako
- Roquette
- Ashland
- Shandong Xinda
- Yunan Yongguang
- Qufu Tianli
- Zibo Qianhui
- Jiangsu Fengyuan
- Mengzhou Huaxing
- Mengzhou Hongji
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Cyclodextrin in Pharma Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Cyclodextrin in Pharma Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Cyclodextrin in Pharma Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Cyclodextrin in Pharma Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Cyclodextrin in Pharma Market Dynamics
- 2.1 Cyclodextrin in Pharma Industry Trends
- 2.2 Cyclodextrin in Pharma Industry Drivers
- 2.3 Cyclodextrin in Pharma Industry Opportunities and Challenges
- 2.4 Cyclodextrin in Pharma Industry Restraints
3 Cyclodextrin in Pharma Market by Manufacturers
- 3.1 Global Cyclodextrin in Pharma Production Value by Manufacturers (2021-2026)
- 3.2 Global Cyclodextrin in Pharma Production by Manufacturers (2021-2026)
- 3.3 Global Cyclodextrin in Pharma Average Price by Manufacturers (2021-2026)
- 3.4 Global Cyclodextrin in Pharma Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cyclodextrin in Pharma Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cyclodextrin in Pharma Manufacturers, Product Type & Application
- 3.7 Global Cyclodextrin in Pharma Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cyclodextrin in Pharma Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cyclodextrin in Pharma Players Market Share by Production Value in 2025
- 3.8.3 2025 Cyclodextrin in Pharma Tier 1, Tier 2, and Tier 3
4 Cyclodextrin in Pharma Market by Type
- 4.1 Cyclodextrin in Pharma Type Introduction
- 4.1.1 Alpha-Cyclodextrin in Pharma
- 4.1.2 Beta-Cyclodextrin in Pharma
- 4.1.3 Gamma-Cyclodextrin in Pharma
- 4.1.4 CD Derivatives
- 4.2 Global Cyclodextrin in Pharma Production by Type
- 4.2.1 Global Cyclodextrin in Pharma Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cyclodextrin in Pharma Production by Type (2021-2032)
- 4.2.3 Global Cyclodextrin in Pharma Production Market Share by Type (2021-2032)
- 4.3 Global Cyclodextrin in Pharma Production Value by Type
- 4.3.1 Global Cyclodextrin in Pharma Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cyclodextrin in Pharma Production Value by Type (2021-2032)
- 4.3.3 Global Cyclodextrin in Pharma Production Value Market Share by Type (2021-2032)
5 Cyclodextrin in Pharma Market by Application
- 5.1 Cyclodextrin in Pharma Application Introduction
- 5.1.1 Tablets and Capsules
- 5.1.2 Injectables
- 5.2 Global Cyclodextrin in Pharma Production by Application
- 5.2.1 Global Cyclodextrin in Pharma Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cyclodextrin in Pharma Production by Application (2021-2032)
- 5.2.3 Global Cyclodextrin in Pharma Production Market Share by Application (2021-2032)
- 5.3 Global Cyclodextrin in Pharma Production Value by Application
- 5.3.1 Global Cyclodextrin in Pharma Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cyclodextrin in Pharma Production Value by Application (2021-2032)
- 5.3.3 Global Cyclodextrin in Pharma Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Wacker
- 6.1.1 Wacker Company Information
- 6.1.2 Wacker Business Overview
- 6.1.3 Wacker Cyclodextrin in Pharma Production, Value and Gross Margin (2021-2026)
- 6.1.4 Wacker Cyclodextrin in Pharma Product Portfolio
- 6.1.5 Wacker Recent Developments
- 6.2 Ensuiko Sugar Refining
- 6.2.1 Ensuiko Sugar Refining Company Information
- 6.2.2 Ensuiko Sugar Refining Business Overview
- 6.2.3 Ensuiko Sugar Refining Cyclodextrin in Pharma Production, Value and Gross Margin (2021-2026)
- 6.2.4 Ensuiko Sugar Refining Cyclodextrin in Pharma Product Portfolio
- 6.2.5 Ensuiko Sugar Refining Recent Developments
- 6.3 Nihon Shokuhin Kako
- 6.3.1 Nihon Shokuhin Kako Company Information
- 6.3.2 Nihon Shokuhin Kako Business Overview
- 6.3.3 Nihon Shokuhin Kako Cyclodextrin in Pharma Production, Value and Gross Margin (2021-2026)
- 6.3.4 Nihon Shokuhin Kako Cyclodextrin in Pharma Product Portfolio
- 6.3.5 Nihon Shokuhin Kako Recent Developments
- 6.4 Roquette
- 6.4.1 Roquette Company Information
- 6.4.2 Roquette Business Overview
- 6.4.3 Roquette Cyclodextrin in Pharma Production, Value and Gross Margin (2021-2026)
- 6.4.4 Roquette Cyclodextrin in Pharma Product Portfolio
- 6.4.5 Roquette Recent Developments
- 6.5 Ashland
- 6.5.1 Ashland Company Information
- 6.5.2 Ashland Business Overview
- 6.5.3 Ashland Cyclodextrin in Pharma Production, Value and Gross Margin (2021-2026)
- 6.5.4 Ashland Cyclodextrin in Pharma Product Portfolio
- 6.5.5 Ashland Recent Developments
- 6.6 Shandong Xinda
- 6.6.1 Shandong Xinda Company Information
- 6.6.2 Shandong Xinda Business Overview
- 6.6.3 Shandong Xinda Cyclodextrin in Pharma Production, Value and Gross Margin (2021-2026)
- 6.6.4 Shandong Xinda Cyclodextrin in Pharma Product Portfolio
- 6.6.5 Shandong Xinda Recent Developments
- 6.7 Yunan Yongguang
- 6.7.1 Yunan Yongguang Company Information
- 6.7.2 Yunan Yongguang Business Overview
- 6.7.3 Yunan Yongguang Cyclodextrin in Pharma Production, Value and Gross Margin (2021-2026)
- 6.7.4 Yunan Yongguang Cyclodextrin in Pharma Product Portfolio
- 6.7.5 Yunan Yongguang Recent Developments
- 6.8 Qufu Tianli
- 6.8.1 Qufu Tianli Company Information
- 6.8.2 Qufu Tianli Business Overview
- 6.8.3 Qufu Tianli Cyclodextrin in Pharma Production, Value and Gross Margin (2021-2026)
- 6.8.4 Qufu Tianli Cyclodextrin in Pharma Product Portfolio
- 6.8.5 Qufu Tianli Recent Developments
- 6.9 Zibo Qianhui
- 6.9.1 Zibo Qianhui Company Information
- 6.9.2 Zibo Qianhui Business Overview
- 6.9.3 Zibo Qianhui Cyclodextrin in Pharma Production, Value and Gross Margin (2021-2026)
- 6.9.4 Zibo Qianhui Cyclodextrin in Pharma Product Portfolio
- 6.9.5 Zibo Qianhui Recent Developments
- 6.10 Jiangsu Fengyuan
- 6.10.1 Jiangsu Fengyuan Company Information
- 6.10.2 Jiangsu Fengyuan Business Overview
- 6.10.3 Jiangsu Fengyuan Cyclodextrin in Pharma Production, Value and Gross Margin (2021-2026)
- 6.10.4 Jiangsu Fengyuan Cyclodextrin in Pharma Product Portfolio
- 6.10.5 Jiangsu Fengyuan Recent Developments
- 6.11 Mengzhou Huaxing
- 6.11.1 Mengzhou Huaxing Company Information
- 6.11.2 Mengzhou Huaxing Business Overview
- 6.11.3 Mengzhou Huaxing Cyclodextrin in Pharma Production, Value and Gross Margin (2021-2026)
- 6.11.4 Mengzhou Huaxing Cyclodextrin in Pharma Product Portfolio
- 6.11.5 Mengzhou Huaxing Recent Developments
- 6.12 Mengzhou Hongji
- 6.12.1 Mengzhou Hongji Company Information
- 6.12.2 Mengzhou Hongji Business Overview
- 6.12.3 Mengzhou Hongji Cyclodextrin in Pharma Production, Value and Gross Margin (2021-2026)
- 6.12.4 Mengzhou Hongji Cyclodextrin in Pharma Product Portfolio
- 6.12.5 Mengzhou Hongji Recent Developments
7 Global Cyclodextrin in Pharma Production by Region
- 7.1 Global Cyclodextrin in Pharma Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Cyclodextrin in Pharma Production by Region (2021-2032)
- 7.2.1 Global Cyclodextrin in Pharma Production by Region (2021-2026)
- 7.2.2 Global Cyclodextrin in Pharma Production Forecast by Region (2027-2032)
- 7.3 Global Cyclodextrin in Pharma Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Cyclodextrin in Pharma Production Value by Region (2021-2032)
- 7.4.1 Global Cyclodextrin in Pharma Production Value by Region (2021-2026)
- 7.4.2 Global Cyclodextrin in Pharma Production Value by Region (2027-2032)
- 7.5 Global Cyclodextrin in Pharma Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Cyclodextrin in Pharma Production Value (2021-2032)
- 7.6.2 Europe Cyclodextrin in Pharma Production Value (2021-2032)
- 7.6.3 Asia-Pacific Cyclodextrin in Pharma Production Value (2021-2032)
- 7.6.4 South America Cyclodextrin in Pharma Production Value (2021-2032)
- 7.6.5 Middle East & Africa Cyclodextrin in Pharma Production Value (2021-2032)
8 Global Cyclodextrin in Pharma Consumption by Region
- 8.1 Global Cyclodextrin in Pharma Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Cyclodextrin in Pharma Consumption by Region (2021-2032)
- 8.2.1 Global Cyclodextrin in Pharma Consumption by Region (2021-2026)
- 8.2.2 Global Cyclodextrin in Pharma Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Cyclodextrin in Pharma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Cyclodextrin in Pharma Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Cyclodextrin in Pharma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Cyclodextrin in Pharma Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Cyclodextrin in Pharma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Cyclodextrin in Pharma Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Cyclodextrin in Pharma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Cyclodextrin in Pharma Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Cyclodextrin in Pharma Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Cyclodextrin in Pharma Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Cyclodextrin in Pharma Value Chain Analysis
- 9.1.1 Cyclodextrin in Pharma Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cyclodextrin in Pharma Production Mode & Process
- 9.2 Cyclodextrin in Pharma Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cyclodextrin in Pharma Distributors
- 9.2.3 Cyclodextrin in Pharma Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst